103 related articles for article (PubMed ID: 21190853)
1. Synthesis of modified siRNA bearing C-5 polyamine-substituted pyrimidine nucleoside in their 3'-overhang regions and its RNAi activity.
Masud MM; Masuda T; Inoue Y; Kuwahara M; Sawai H; Ozaki H
Bioorg Med Chem Lett; 2011 Jan; 21(2):715-7. PubMed ID: 21190853
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and properties of modified siRNA having amide-linked oligoribonucleosides at their 3' overhang regions.
Iwase R; Miyao H; Toyama T; Nishimori K
Nucleic Acids Symp Ser (Oxf); 2006; (50):175-6. PubMed ID: 17150874
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of nuclease-resistant siRNAs possessing universal overhangs.
Ueno Y; Watanabe Y; Shibata A; Yoshikawa K; Takano T; Kohara M; Kitade Y
Bioorg Med Chem; 2009 Mar; 17(5):1974-81. PubMed ID: 19200743
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of nuclease-resistant siRNAs possessing benzene-phosphate backbones in their 3'-overhang regions.
Ueno Y; Inoue T; Yoshida M; Yoshikawa K; Shibata A; Kitamura Y; Kitade Y
Bioorg Med Chem Lett; 2008 Oct; 18(19):5194-6. PubMed ID: 18783944
[TBL] [Abstract][Full Text] [Related]
5. RNAi activity of siRNAs modified with 2'-aminoalkyl-substituted fluorinated nucleobases.
Haas J; Mueller-Kuller T; Klein S; Engels JW
Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):865-8. PubMed ID: 18066915
[TBL] [Abstract][Full Text] [Related]
6. Suppression of bcr-abl mRNA by chemically modified siRNA.
Murao S; Diala I; Fujii M
Nucleic Acids Symp Ser (Oxf); 2008; (52):499-500. PubMed ID: 18776472
[TBL] [Abstract][Full Text] [Related]
7. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of modified double stranded RNAs containing duplex regions between amide-linked RNA and RNA at both ends and enhanced nuclease resistance.
Iwase R; Kurokawa R; Ueno J
Nucleic Acids Symp Ser (Oxf); 2009; (53):119-20. PubMed ID: 19749289
[TBL] [Abstract][Full Text] [Related]
9. RNA interference induced by siRNAs modified with 4'-thioribonucleosides in cultured mammalian cells.
Hoshika S; Minakawa N; Kamiya H; Harashima H; Matsuda A
FEBS Lett; 2005 Jun; 579(14):3115-8. PubMed ID: 15919084
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel siRNAs having thymidine dimers consisting of a carbamate or a urea linkage at their 3' overhang regions and their ability to suppress human RNase L protein expression.
Ueno Y; Naito T; Kawada K; Shibata A; Kim HS; Wataya Y; Kitade Y
Biochem Biophys Res Commun; 2005 May; 330(4):1168-75. PubMed ID: 15823566
[TBL] [Abstract][Full Text] [Related]
11. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
Takahashi Y; Nishikawa M; Takakura Y
Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
[TBL] [Abstract][Full Text] [Related]
12. Studies on aminoisonucleoside modified siRNAs: stability and silencing activity.
Li ZS; Qiao RP; Du Q; Yang ZJ; Zhang LR; Zhang PZ; Liang ZC; Zhang LH
Bioconjug Chem; 2007; 18(4):1017-24. PubMed ID: 17539595
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 2'-O-modified adenosine building blocks and application for RNA interference.
Odadzic D; Bramsen JB; Smicius R; Bus C; Kjems J; Engels JW
Bioorg Med Chem; 2008 Jan; 16(1):518-29. PubMed ID: 17904849
[TBL] [Abstract][Full Text] [Related]
14. Contributions of 3'-overhang to the dissociation of small interfering RNAs from the PAZ domain: molecular dynamics simulation study.
Lee HS; Lee SN; Joo CH; Lee H; Lee HS; Yoon SY; Kim YK; Choe H
J Mol Graph Model; 2007 Mar; 25(6):784-93. PubMed ID: 16959510
[TBL] [Abstract][Full Text] [Related]
15. Dissecting RNA-interference pathway with small molecules.
Chiu YL; Dinesh CU; Chu CY; Ali A; Brown KM; Cao H; Rana TM
Chem Biol; 2005 Jun; 12(6):643-8. PubMed ID: 15975509
[TBL] [Abstract][Full Text] [Related]
16. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
Bartlett DW; Davis ME
Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
[TBL] [Abstract][Full Text] [Related]
17. RNA interference (RNAi) in hematology.
Scherr M; Steinmann D; Eder M
Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric RNA duplexes mediate RNA interference in mammalian cells.
Sun X; Rogoff HA; Li CJ
Nat Biotechnol; 2008 Dec; 26(12):1379-82. PubMed ID: 19029911
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatic approaches to siRNA selection and optimization.
Muhonen P; Holthofer H
Methods Mol Biol; 2010; 623():93-107. PubMed ID: 20217546
[TBL] [Abstract][Full Text] [Related]
20. RNA interference in mammalian cells by siRNAs modified with morpholino nucleoside analogues.
Zhang N; Tan C; Cai P; Zhang P; Zhao Y; Jiang Y
Bioorg Med Chem; 2009 Mar; 17(6):2441-6. PubMed ID: 19233658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]